Evidence map›Paper›PMID 26000334›Full record

ArticleCellular and molecular gastroenterology and hepatology2015

Experimental Models of Inflammatory Bowel Diseases.

Patricia Kiesler, Ivan J Fuss, Warren Strober

Open access · goldAbstract read
In one paragraph

Article in Cellular and molecular gastroenterology and hepatology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 406 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
406citing papers in PubMed, 1 pooled it
35.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

406 citing papers in PubMed, 1 synthesis or guideline pooled it, 700 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. UBE2L6 drives ulcerative colitis progression by promoting BIRC2 degradation and activating non-canonical NF-κB signalling.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2026
    Article
  5. Article
  6. Review
  7. Arctic Fox-DerivedLife (Basel, Switzerland) · 2026
    Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

346 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Patricia KieslerMucosal Immunity Section, Laboratory of Host Defenses, National Institutes of Health.
Ivan J FussMucosal Immunity Section, Laboratory of Host Defenses, National Institutes of Health.
Warren StroberMucosal Immunity Section, Laboratory of Host Defenses, National Institutes of Health.
National Institutes of Health · US

Funding

Regulation of T cell DifferentiationZIAAI000872 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI STROBER, WARREN · 2009 to 2025
$9.6M
Immunoregulatory Defects In Inflammatory Bowel DiseaseZIAAI000354 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI STROBER, WARREN · 2009 to 2025
$8.7M
Clinical Studies of Inflammatory Bowel DiseasesZIAAI000903 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI STROBER, WARREN · 2009 to 2025
$5.9M
STUDIES OF IMMUNOREGULATORY DEFECTS PRESENT IN INFLAMMATORY BOWEL DISEASEZ01AI000354 · NIAID · NIAID EXTRAMURAL ACTIVITIES · PI STROBER, WARREN · 1985 to 2008
$2.1M
Intramural NIH HHS Z01 AI000354
6 · The paper itself

Abstract

The understanding of the intestinal inflammation occurring in the inflammatory bowel diseases (IBD) has been immeasurably advanced by the development of the now numerous murine models of intestinal inflammation. The usefulness of this research tool in IBD studies has been enabled by our improved knowledge of mucosal immunity and thus our improved ability to interpret the complex responses of mice with various causes of colitis; in addition, it has been powered by the availability of models in which the mice have specific genetic and/or immunologic defects that can be related to the origin of the inflammation. Finally, and more recently, it has been enhanced by our newly acquired ability to define the intestinal microbiome under various conditions and thus to understand how intestinal microorganisms impact on inflammation. In this brief review of murine models of intestinal inflammation we focus mainly on the most often used models that are, not incidentally, also the models that have yielded major insights into IBD pathogenesis.

Indexed as

Cell Transfer ColitisDSS ColitisIL-10 DeficiencyMurine colitis modelsNKT CellsOxazolone ColitisTh17 CellsTh1 CellsTNBS ColitisTregs

Identifiers

PMID26000334
PMCPMC4435576
OpenAlexW2144898082

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.